Skip to main content
Erschienen in:

01.06.2019 | Case report

Sirolimus

Line sepsis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Dastamani A, et al. The use of a long-acting somatostatin analogue (lanreotide) in three children with focal forms of congenital hyperinsulinaemic hypoglycaemia. Hormone Research in Paediatrics 91: 56-61, No. 1, May 2019. Available from: URL: http://doi.org/10.1159/000491101 - United KingdomCrossRefPubMed Dastamani A, et al. The use of a long-acting somatostatin analogue (lanreotide) in three children with focal forms of congenital hyperinsulinaemic hypoglycaemia. Hormone Research in Paediatrics 91: 56-61, No. 1, May 2019. Available from: URL: http://​doi.​org/​10.​1159/​000491101 - United KingdomCrossRefPubMed
Metadaten
Titel
Sirolimus
Line sepsis: 2 case reports
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-64129-0